Page last updated: 2024-08-23

bromocriptine and Leukocytosis

bromocriptine has been researched along with Leukocytosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Apramian, A; Kajani, R; Liu, A; Ubhayakar, N; Vega, A; Xu, P1
Majid, H; Zubair, UB1
Munitz, H; Shalev, A1

Reviews

1 review(s) available for bromocriptine and Leukocytosis

ArticleYear
The neuroleptic malignant syndrome: agent and host interaction.
    Acta psychiatrica Scandinavica, 1986, Volume: 73, Issue:4

    Topics: Adolescent; Adult; Aftercare; Aged; Akathisia, Drug-Induced; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Carbidopa; Child; Child, Preschool; Dantrolene; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Female; Haloperidol; Humans; Leukocytosis; Male; Middle Aged; Neuroleptic Malignant Syndrome

1986

Other Studies

2 other study(ies) available for bromocriptine and Leukocytosis

ArticleYear
Neuroleptic malignant syndrome in a COVID-19 patient.
    Brain, behavior, and immunity, 2020, Volume: 88

    Topics: Acute Kidney Injury; Antipsychotic Agents; Betacoronavirus; Bromocriptine; C-Reactive Protein; Coronavirus Infections; COVID-19; Dantrolene; Dopamine Agonists; Enzyme Inhibitors; Haloperidol; Humans; Hydroxychloroquine; Intensive Care Units; Leukocytosis; Lymphopenia; Male; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Pandemics; Pneumonia, Viral; Renal Dialysis; Respiration, Artificial; Rhabdomyolysis; SARS-CoV-2; Schizophrenia

2020
Anti-NMDA Receptor Encephalitis in a Young Girl with Altered Behaviour and Abnormal Movements.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2018, Volume: 28, Issue:8

    Topics: Adolescent; Amantadine; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Autoantibodies; Bromocriptine; Dyskinesias; Female; Humans; Leukocytosis; Methylprednisolone; Nervous System Diseases; Receptors, N-Methyl-D-Aspartate; Treatment Outcome

2018